semaglutide for bmi 25 Oral Wegovy approved obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Semaglutide cuts BMI by 19%
Pay in 4 interest-free payments of $6.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 21 - Nov 26


00164-0/asset/0b8acb02-4bf6-48ab-a1f7-50e7fc8f0e66/main.assets/gr3_lrg.jpg)






00305-3/asset/e4d9e37e-b274-4b15-adaf-e8d549a8bd51/main.assets/gr2_lrg.jpg)











